537 / 1726
•
139 patients, all EMBRACE
•
All stages cervix cancer, 84 N1
•
209 nodes identified
•
D98 mean 62 Gy EQD2 (53 to 69)
•
Including BT contribution
•
Excellent control in boosted nodes
•
Initial SUVmax higher in nodes that relapsed
•
More failures when chemo < 5 cycles
No relation initial node volume - dose - failure
Dose to macroscopic nodal disease